NCT07310186 2025-12-30
Treatment and Outcomes of DLBCL After Progression on Polatuzumab Vedotin-based Combination Therapy
Peking Union Medical College Hospital
Not yet recruiting
Clinical Trials
3 trialsNCT06084923 2024-04-10
Outcomes of Unfit Patients With CLL Included in the GIMEMA LLC1114 Trial Who Discontinued Ibrutinib Due to Reasons Other Than Disease Progression
Gruppo Italiano Malattie EMatologiche dell'Adulto
Not yet recruiting
NCT05746858 2023-02-28
MIMOSA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Not yet recruiting